Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 117

    1.

    Suboptimal monitoring and dosing of unfractionated heparin.

    Chung KK, Tofferi JK, Browne WT.

    Ann Intern Med. 2004 Apr 6;140(7):582; author reply 582-3. No abstract available. PMID: 15068994 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Nomograms for the administration of unfractionated heparin.

    Grubb H, Lovett J, Kingman HM, Copplestone JA, Prentice AG.

    Thromb Haemost. 2001 Mar;85(3):565. No abstract available. PMID: 11307835 [PubMed - indexed for MEDLINE]Related articles

    3.

    Weight-based heparin dosing: maybe it's just a matter of time.

    Susla GM.

    Crit Care Med. 1997 Sep;25(9):1451-2. No abstract available. PMID: 9295812 [PubMed - indexed for MEDLINE]Related articles

    4.

    A standardized weight-based heparin protocol. Improving clinical outcomes.

    Lechner DL.

    Nurs Manage. 1997 Apr;28(4):29-32.PMID: 9287775 [PubMed - indexed for MEDLINE]Related articles

    5.

    Heparin nomograms: time for change.

    Dunkley S.

    Intern Med J. 2003 Dec;33(12):623-4; author reply 624. No abstract available. PMID: 14656245 [PubMed - indexed for MEDLINE]Related articles

    6.

    Redesign of a weight-based heparin protocol for improved outcomes in a community hospital.

    Stahl KL, Pollard DL.

    J Nurs Care Qual. 2003 Jul-Sep;18(3):193-201.PMID: 12856903 [PubMed - indexed for MEDLINE]Related articles

    7.

    When monitoring laboratory results failed: a case study.

    Meiner SE.

    Geriatr Nurs. 1999 Nov-Dec;20(6):320, 326. No abstract available. PMID: 10601897 [PubMed - indexed for MEDLINE]Related articles

    8.

    Monitoring unfractionated heparin with the aPTT: time for a fresh look.

    Eikelboom JW, Hirsh J.

    Thromb Haemost. 2006 Nov;96(5):547-52. Review.PMID: 17080209 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of pre-analytical variables on the anti-activated factor X chromogenic assay when monitoring unfractionated heparin and low molecular weight heparin anticoagulation.

    McGlasson DL, Kaczor DA, Krasuski RA, Campbell CL, Kostur MR, Adinaro JT.

    Blood Coagul Fibrinolysis. 2005 Apr;16(3):173-6.PMID: 15795534 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prescribing and monitoring heparin.

    Higginson AJ, Kay EA.

    J Clin Pharm Ther. 1988 Dec;13(6):381-4.PMID: 3235482 [PubMed - indexed for MEDLINE]Related articles

    11.

    Achieving target antifactor Xa activity with a heparin protocol based on sex, age, height, and weight.

    Rosborough TK, Shepherd MF.

    Pharmacotherapy. 2004 Jun;24(6):713-9.PMID: 15222660 [PubMed - indexed for MEDLINE]Related articles

    12.

    Sizing up your patients for heparin therapy.

    Lechner DL.

    Nursing. 1998 Aug;28(8):36-41; quiz 41-2. Review. No abstract available. PMID: 9739252 [PubMed - indexed for MEDLINE]Related articles

    13.

    Subcutaneous unfractionated heparin for the treatment of venous thromboembolism.

    Kearon C.

    Curr Opin Pulm Med. 2007 Sep;13(5):398-402. Review.PMID: 17940484 [PubMed - indexed for MEDLINE]Related articles

    14.

    Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill children.

    Kuhle S, Eulmesekian P, Kavanagh B, Massicotte P, Vegh P, Lau A, Mitchell LG.

    Haematologica. 2007 Apr;92(4):554-7.PMID: 17488668 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.

    Spinler SA, Wittkowsky AK, Nutescu EA, Smythe MA.

    Ann Pharmacother. 2005 Jul-Aug;39(7-8):1275-85. Epub 2005 Jun 14. Review.PMID: 15956240 [PubMed - indexed for MEDLINE]Related articles

    16.

    Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

    Kearon C, Ginsberg JS, Julian JA, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AG, MacKinnon B, Hirsh J, Gent M; Fixed-Dose Heparin (FIDO) Investigators.

    JAMA. 2006 Aug 23;296(8):935-42.PMID: 16926353 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR).

    Tremey B, Szekely B, Schlumberger S, François D, Liu N, Sievert K, Fischler M.

    Br J Anaesth. 2006 Oct;97(4):453-9. Epub 2006 Jul 27.PMID: 16873382 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    [Monitoring of heparin therapy during extracorporeal bypass: what are the remaining questions?]

    Jude B, Lasne D, Mouton C, de Moerloose P; Groupe de travail "Hémostase circulation extracorporelle"; Groupe d'études sur l'hémostase et la thrombose; Groupe d'intérêt en hémostase périopératoire.

    Ann Fr Anesth Reanim. 2004 Jun;23(6):589-96. Review. French. PMID: 15234724 [PubMed - indexed for MEDLINE]Related articles

    19.

    Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction.

    DeCarolis DD.

    N Engl J Med. 2006 Jun 29;354(26):2830; author reply 2831-2. No abstract available. PMID: 16807424 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comparison of heparin administration using the Rapidpoint Coag and Hepcon HMS.

    Newsome J, Stipanovich K, Flaherty S.

    J Extra Corpor Technol. 2004 Jun;36(2):139-44.PMID: 15334753 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data